Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Relay Therapeutics, Inc. (RLAY) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Relay Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1812364.
Total stock buying since 2020: $2,200,000.
Total stock sales since 2020: $271,496,182.
Total stock option exercises since 2020: $4,842,757.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 0 | $0 | 564,370 | $8,881,908 | 264,702 | $1,225,227 |
| 2025 | 0 | $0 | 1,483,237 | $6,470,513 | 0 | $0 |
| 2024 | 0 | $0 | 373,135 | $2,633,470 | 128,948 | $649,897 |
| 2023 | 0 | $0 | 155,109 | $2,928,535 | 126,000 | $635,040 |
| 2022 | 0 | $0 | 447,764 | $11,642,284 | 393,543 | $1,660,036 |
| 2021 | 0 | $0 | 5,819,343 | $238,939,472 | 163,242 | $672,557 |
| 2020 | 110,000 | $2,200,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-06 | 0 | $0 | 430,619 | $7,624,671 | 262,902 | $1,215,831 |
| 2026-05 | 0 | $0 | 17,717 | $227,840 | 0 | $0 |
| 2026-04 | 0 | $0 | 22,732 | $305,046 | 1,800 | $9,396 |
| 2026-01 | 0 | $0 | 93,302 | $724,351 | 0 | $0 |
| 2025-11 | 0 | $0 | 62,073 | $434,511 | 0 | $0 |
| 2025-10 | 0 | $0 | 93,090 | $683,118 | 0 | $0 |
| 2025-07 | 0 | $0 | 149,226 | $542,922 | 0 | $0 |
| 2025-04 | 0 | $0 | 261,709 | $782,078 | 0 | $0 |
| 2025-03 | 0 | $0 | 6,395 | $18,160 | 0 | $0 |
| 2025-02 | 0 | $0 | 215,506 | $818,398 | 0 | $0 |
| 2025-01 | 0 | $0 | 695,238 | $3,191,326 | 0 | $0 |
| 2024-12 | 0 | $0 | 106,221 | $527,344 | 0 | $0 |
| 2024-10 | 0 | $0 | 15,043 | $90,906 | 0 | $0 |
| 2024-07 | 0 | $0 | 144,181 | $1,277,772 | 86,706 | $436,998 |
| 2024-06 | 0 | $0 | 91,470 | $608,463 | 42,242 | $212,899 |
| 2024-04 | 0 | $0 | 7,349 | $46,885 | 0 | $0 |
| 2024-03 | 0 | $0 | 1,759 | $13,542 | 0 | $0 |
| 2024-01 | 0 | $0 | 7,112 | $68,558 | 0 | $0 |
| 2023-12 | 0 | $0 | 1,809 | $20,819 | 0 | $0 |
| 2023-10 | 0 | $0 | 8,134 | $49,045 | 0 | $0 |
| 2023-09 | 0 | $0 | 832 | $6,970 | 0 | $0 |
| 2023-07 | 0 | $0 | 7,356 | $86,799 | 0 | $0 |
| 2023-06 | 0 | $0 | 1,479 | $17,924 | 0 | $0 |
| 2023-04 | 0 | $0 | 3,848 | $42,943 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-06-30 | Rahmer Peter (See remarks) | Sale | 100,000 | 19.09 | 1,909,000 |
| 2026-06-22 | Catinazzo Thomas (Chief Financial Officer) | Sale | 187,163 | 16.98 | 3,178,027 |
| 2026-06-22 | Catinazzo Thomas (Chief Financial Officer) | Option Ex | 169,446 | 4.90 | 830,793 |
| 2026-06-22 | Bergstrom Donald A (President, R&D) | Sale | 93,456 | 16.94 | 1,583,144 |
| 2026-06-22 | Bergstrom Donald A (President, R&D) | Option Ex | 93,456 | 4.12 | 385,038 |
| 2026-05-14 | Catinazzo Thomas (Chief Financial Officer) | Sale | 17,717 | 12.86 | 227,840 |
| 2026-04-28 | Rahmer Peter (See remarks) | Sale | 753 | 14.79 | 11,136 |
| 2026-04-28 | Catinazzo Thomas (Chief Financial Officer) | Sale | 972 | 14.79 | 14,375 |
| 2026-04-28 | Bergstrom Donald A (President, R&D) | Sale | 1,490 | 14.79 | 22,037 |
| 2026-04-09 | Catinazzo Thomas (Chief Financial Officer) | Sale | 1,800 | 15.00 | 27,000 |
| 2026-04-09 | Catinazzo Thomas (Chief Financial Officer) | Option Ex | 1,800 | 5.22 | 9,396 |
| 2026-04-07 | Catinazzo Thomas (Chief Financial Officer) | Sale | 17,717 | 13.01 | 230,498 |
| 2026-01-28 | Rahmer Peter (See remarks) | Sale | 1,354 | 8.45 | 11,441 |
| 2026-01-28 | Catinazzo Thomas (Chief Financial Officer) | Sale | 1,695 | 8.45 | 14,322 |
| 2026-01-28 | Bergstrom Donald A (President, R&D) | Sale | 2,686 | 8.45 | 22,696 |
| 2026-01-27 | Rahmer Peter (See remarks) | Sale | 11,684 | 7.62 | 89,032 |
| 2026-01-27 | Catinazzo Thomas (Chief Financial Officer) | Sale | 13,820 | 7.62 | 105,308 |
| 2026-01-27 | Bergstrom Donald A (President, R&D) | Sale | 18,895 | 7.62 | 143,979 |
| 2026-01-06 | Patel Sanjiv (President and CEO) | Sale | 43,168 | 7.82 | 337,573 |
| 2025-11-03 | Patel Sanjiv (President and CEO) | Sale | 62,073 | 7.00 | 434,511 |
| 2025-10-29 | Rahmer Peter (See remarks) | Sale | 21,394 | 7.50 | 160,455 |
| 2025-10-28 | Rahmer Peter (See remarks) | Sale | 19,135 | 7.29 | 139,494 |
| 2025-10-28 | Catinazzo Thomas (Chief Financial Officer) | Sale | 21,664 | 7.29 | 157,930 |
| 2025-10-28 | Bergstrom Donald A (President, R&D) | Sale | 30,897 | 7.29 | 225,239 |
| 2025-07-29 | Rahmer Peter (See remarks) | Sale | 15,724 | 3.68 | 57,864 |
| 2025-07-29 | Catinazzo Thomas (Chief Financial Officer) | Sale | 18,380 | 3.68 | 67,638 |
| 2025-07-29 | Bergstrom Donald A (President, R&D) | Sale | 26,701 | 3.68 | 98,259 |
| 2025-07-29 | Adams Brian (Chief Legal Officer) | Sale | 18,276 | 3.68 | 67,255 |
| 2025-07-28 | Rahmer Peter (See remarks) | Sale | 1,359 | 3.74 | 5,082 |
| 2025-07-28 | Catinazzo Thomas (Chief Financial Officer) | Sale | 1,701 | 3.74 | 6,361 |
| 2025-07-28 | Bergstrom Donald A (President, R&D) | Sale | 4,069 | 3.74 | 15,218 |
| 2025-07-28 | Adams Brian (Chief Legal Officer) | Sale | 1,637 | 3.74 | 6,122 |
| 2025-07-09 | Patel Sanjiv (President and CEO) | Sale | 61,379 | 3.57 | 219,123 |
| 2025-04-30 | Rahmer Peter (See remarks) | Sale | 10,739 | 3.00 | 32,217 |
| 2025-04-30 | Catinazzo Thomas (Chief Financial Officer) | Sale | 12,943 | 3.00 | 38,829 |
| 2025-04-30 | Bergstrom Donald A (President, R&D) | Sale | 27,472 | 3.00 | 82,416 |
| 2025-04-30 | Adams Brian (Chief Legal Officer) | Sale | 12,943 | 3.00 | 38,829 |
| 2025-04-29 | Catinazzo Thomas (Chief Financial Officer) | Sale | 3,558 | 3.23 | 11,492 |
| 2025-04-28 | Rahmer Peter (See remarks) | Sale | 1,364 | 3.17 | 4,323 |
| 2025-04-28 | Catinazzo Thomas (Chief Financial Officer) | Sale | 2,690 | 3.17 | 8,527 |
| 2025-04-28 | Bergstrom Donald A (President, R&D) | Sale | 4,090 | 3.17 | 12,965 |
| 2025-04-28 | Adams Brian (Chief Legal Officer) | Sale | 1,644 | 3.17 | 5,211 |
| 2025-04-23 | Patel Sanjiv (President and CEO) | Sale | 122,844 | 2.97 | 364,846 |
| 2025-03-27 | Rahmer Peter (See remarks) | Sale | 247 | 2.84 | 701 |
| 2025-03-27 | Catinazzo Thomas (Chief Financial Officer) | Sale | 4,864 | 2.84 | 13,813 |
| 2025-03-27 | Bergstrom Donald A (President, R&D) | Sale | 986 | 2.84 | 2,800 |
| 2025-03-27 | Adams Brian (Chief Legal Officer) | Sale | 298 | 2.84 | 846 |
| 2025-02-13 | Patel Sanjiv (President and CEO) | Sale | 75,324 | 3.70 | 278,698 |
| 2025-02-11 | Patel Sanjiv (President and CEO) | Sale | 140,182 | 3.85 | 539,700 |
| 2025-01-30 | Rahmer Peter (See remarks) | Sale | 17,250 | 4.42 | 76,245 |
| 2025-01-30 | Catinazzo Thomas (Chief Financial Officer) | Sale | 20,791 | 4.42 | 91,896 |
| 2025-01-30 | Bergstrom Donald A (President, R&D) | Sale | 30,823 | 4.42 | 136,237 |
| 2025-01-30 | Adams Brian (Chief Legal Officer) | Sale | 20,791 | 4.42 | 91,896 |
| 2025-01-29 | Rahmer Peter (See remarks) | Sale | 26,541 | 4.55 | 120,761 |
| 2025-01-29 | Catinazzo Thomas (Chief Financial Officer) | Sale | 2,109 | 4.55 | 9,595 |
| 2025-01-29 | Bergstrom Donald A (President, R&D) | Sale | 46,407 | 4.55 | 211,151 |
| 2025-01-28 | Rahmer Peter (See remarks) | Sale | 1,673 | 4.63 | 7,745 |
| 2025-01-28 | Catinazzo Thomas (Chief Financial Officer) | Sale | 36,036 | 4.63 | 166,846 |
| 2025-01-28 | Bergstrom Donald A (President, R&D) | Sale | 3,220 | 4.63 | 14,908 |
| 2025-01-28 | Adams Brian (Chief Legal Officer) | Sale | 33,688 | 4.63 | 155,975 |
| 2025-01-23 | Patel Sanjiv (President and CEO) | Sale | 125,000 | 4.78 | 597,500 |
| 2025-01-22 | Patel Sanjiv (President and CEO) | Sale | 125,000 | 4.80 | 600,000 |
| 2025-01-21 | Patel Sanjiv (President and CEO) | Sale | 125,000 | 4.52 | 565,000 |
| 2025-01-06 | Rahmer Peter (See remarks) | Sale | 16,576 | 4.45 | 73,763 |
| 2025-01-03 | Rahmer Peter (See remarks) | Sale | 32,177 | 4.30 | 138,361 |
| 2025-01-02 | Rahmer Peter (See remarks) | Sale | 32,156 | 4.15 | 133,447 |
| 2024-12-27 | Rahmer Peter (See remarks) | Sale | 400 | 4.38 | 1,752 |
| 2024-12-27 | Catinazzo Thomas (Chief Financial Officer) | Sale | 4,865 | 4.40 | 21,406 |
| 2024-12-27 | Bergstrom Donald A (President, R&D) | Sale | 657 | 4.38 | 2,877 |
| 2024-12-27 | Adams Brian (Chief Legal Officer) | Sale | 299 | 4.38 | 1,309 |
| 2024-12-16 | Patel Sanjiv (President and CEO) | Sale | 100,000 | 5.00 | 500,000 |
| 2024-10-29 | Catinazzo Thomas (Chief Financial Officer) | Sale | 2,300 | 5.95 | 13,685 |
| 2024-10-28 | Rahmer Peter (See remarks) | Sale | 1,621 | 6.06 | 9,823 |
| 2024-10-28 | Catinazzo Thomas (Chief Financial Officer) | Sale | 6,802 | 6.06 | 41,220 |
| 2024-10-28 | Bergstrom Donald A (President, R&D) | Sale | 2,688 | 6.06 | 16,289 |
| 2024-10-28 | Adams Brian (Chief Legal Officer) | Sale | 1,632 | 6.06 | 9,889 |
| 2024-07-31 | Rahmer Peter (See remarks) | Sale | 13,708 | 8.19 | 112,268 |
| 2024-07-30 | Rahmer Peter (See remarks) | Sale | 15,128 | 8.28 | 125,259 |
| 2024-07-29 | Rahmer Peter (See remarks) | Sale | 13,523 | 8.68 | 117,379 |
| 2024-07-29 | Catinazzo Thomas (Chief Financial Officer) | Sale | 10,780 | 8.68 | 93,570 |
| 2024-07-29 | Bergstrom Donald A (President, R&D) | Sale | 2,698 | 8.85 | 23,877 |
| 2024-07-29 | Adams Brian (Chief Legal Officer) | Sale | 1,638 | 8.85 | 14,496 |
| 2024-07-26 | Patel Sanjiv (President and CEO) | Sale | 36,706 | 9.07 | 332,923 |
| 2024-07-26 | Patel Sanjiv (President and CEO) | Option Ex | 36,706 | 5.04 | 184,998 |
| 2024-07-25 | Patel Sanjiv (President and CEO) | Sale | 50,000 | 9.16 | 458,000 |
| 2024-07-25 | Patel Sanjiv (President and CEO) | Option Ex | 50,000 | 5.04 | 252,000 |
| 2024-06-27 | Rahmer Peter (See remarks) | Sale | 245 | 6.26 | 1,533 |
| 2024-06-27 | Catinazzo Thomas (Chief Financial Officer) | Sale | 9,373 | 6.25 | 58,581 |
| 2024-06-27 | Bergstrom Donald A (President, R&D) | Sale | 648 | 6.26 | 4,056 |
| 2024-06-27 | Adams Brian (Chief Legal Officer) | Sale | 295 | 6.26 | 1,846 |
| 2024-06-10 | Rubin Jami | Option Ex | 42,242 | 5.04 | 212,899 |
| 2024-06-05 | Rahmer Peter (See remarks) | Sale | 20,450 | 7.06 | 144,377 |
| 2024-06-04 | Rahmer Peter (See remarks) | Sale | 40,595 | 6.64 | 269,550 |
| 2024-06-03 | Rahmer Peter (See remarks) | Sale | 19,864 | 6.47 | 128,520 |
| 2024-04-29 | Rahmer Peter (See remarks) | Sale | 1,345 | 6.38 | 8,581 |
| 2024-04-29 | Catinazzo Thomas (Chief Financial Officer) | Sale | 1,695 | 6.38 | 10,814 |
| 2024-04-29 | Bergstrom Donald A (President, R&D) | Sale | 2,686 | 6.38 | 17,136 |
| 2024-04-29 | Adams Brian (Chief Legal Officer) | Sale | 1,623 | 6.38 | 10,354 |
| 2024-03-27 | Rahmer Peter (See remarks) | Sale | 298 | 7.70 | 2,294 |
| 2024-03-27 | Catinazzo Thomas (Chief Financial Officer) | Sale | 348 | 7.70 | 2,679 |
| 2024-03-27 | Bergstrom Donald A (President, R&D) | Sale | 765 | 7.70 | 5,890 |
| 2024-03-27 | Adams Brian (Chief Legal Officer) | Sale | 348 | 7.70 | 2,679 |
| 2024-01-29 | Catinazzo Thomas (Chief Financial Officer) | Sale | 2,005 | 9.64 | 19,328 |
| 2024-01-29 | Bergstrom Donald A (President, R&D) | Sale | 3,178 | 9.64 | 30,635 |
| 2024-01-29 | Adams Brian (Chief Legal Officer) | Sale | 1,929 | 9.64 | 18,595 |
| 2023-12-27 | Rahmer Peter (See remarks) | Sale | 244 | 11.51 | 2,808 |
| 2023-12-27 | Catinazzo Thomas (Chief Financial Officer) | Sale | 294 | 11.51 | 3,383 |
| 2023-12-27 | Bergstrom Donald A (President, R&D) | Sale | 977 | 11.51 | 11,245 |
| 2023-12-27 | Adams Brian (Chief Legal Officer) | Sale | 294 | 11.51 | 3,383 |
| 2023-10-30 | Rahmer Peter (See remarks) | Sale | 1,354 | 6.03 | 8,164 |
| 2023-10-30 | Catinazzo Thomas (Chief Financial Officer) | Sale | 1,697 | 6.03 | 10,232 |
| 2023-10-30 | Bergstrom Donald A (President, R&D) | Sale | 3,451 | 6.03 | 20,809 |
| 2023-10-30 | Adams Brian (Chief Legal Officer) | Sale | 1,632 | 6.03 | 9,840 |
| 2023-09-27 | Rahmer Peter (See remarks) | Sale | 244 | 8.38 | 2,044 |
| 2023-09-27 | Catinazzo Thomas (Chief Financial Officer) | Sale | 294 | 8.38 | 2,463 |
| 2023-09-27 | Adams Brian (Chief Legal Officer) | Sale | 294 | 8.38 | 2,463 |
| 2023-07-28 | Rahmer Peter (See remarks) | Sale | 1,352 | 11.80 | 15,953 |
| 2023-07-28 | Catinazzo Thomas (Chief Financial Officer) | Sale | 1,693 | 11.80 | 19,977 |
| 2023-07-28 | Bergstrom Donald A (President, R&D) | Sale | 2,683 | 11.80 | 31,659 |
| 2023-07-28 | Adams Brian (Chief Legal Officer) | Sale | 1,628 | 11.80 | 19,210 |
| 2023-06-27 | Rahmer Peter (See remarks) | Sale | 244 | 12.12 | 2,957 |
| 2023-06-27 | Catinazzo Thomas (Chief Financial Officer) | Sale | 294 | 12.12 | 3,563 |
| 2023-06-27 | Bergstrom Donald A (President, R&D) | Sale | 647 | 12.12 | 7,841 |
| 2023-06-27 | Adams Brian (Chief Legal Officer) | Sale | 294 | 12.12 | 3,563 |
| 2023-04-28 | Rahmer Peter (See remarks) | Sale | 739 | 11.16 | 8,247 |
| 2023-04-28 | Catinazzo Thomas (Chief Financial Officer) | Sale | 863 | 11.16 | 9,631 |
| 2023-04-28 | Bergstrom Donald A (President, R&D) | Sale | 1,383 | 11.16 | 15,434 |
| 2023-04-28 | Adams Brian (Chief Legal Officer) | Sale | 863 | 11.16 | 9,631 |
| 2023-03-27 | Rahmer Peter (See remarks) | Sale | 297 | 15.36 | 4,561 |
| 2023-03-27 | Catinazzo Thomas (Chief Financial Officer) | Sale | 347 | 15.36 | 5,329 |
| 2023-03-27 | Bergstrom Donald A (President, R&D) | Sale | 763 | 15.36 | 11,719 |
| 2023-03-27 | Adams Brian (Chief Legal Officer) | Sale | 347 | 15.36 | 5,329 |
| 2023-02-09 | Patel Sanjiv (President and CEO) | Sale | 14,000 | 20.55 | 287,700 |
| 2023-02-09 | Patel Sanjiv (President and CEO) | Option Ex | 14,000 | 5.04 | 70,560 |
| 2023-02-08 | Patel Sanjiv (President and CEO) | Sale | 14,000 | 20.98 | 293,720 |
| 2023-02-08 | Patel Sanjiv (President and CEO) | Option Ex | 14,000 | 5.04 | 70,560 |
| 2023-02-07 | Patel Sanjiv (President and CEO) | Sale | 14,000 | 21.45 | 300,300 |
| 2023-02-07 | Patel Sanjiv (President and CEO) | Option Ex | 14,000 | 5.04 | 70,560 |
| 2023-01-30 | Rahmer Peter (See remarks) | Sale | 740 | 21.56 | 15,954 |
| 2023-01-30 | Catinazzo Thomas (Chief Financial Officer) | Sale | 864 | 21.56 | 18,627 |
| 2023-01-30 | Bergstrom Donald A (President, R&D) | Sale | 1,429 | 21.56 | 30,809 |
| 2023-01-30 | Adams Brian (Chief Legal Officer) | Sale | 864 | 21.56 | 18,627 |
| 2023-01-19 | Patel Sanjiv (President and CEO) | Sale | 28,000 | 20.02 | 560,560 |
| 2023-01-19 | Patel Sanjiv (President and CEO) | Option Ex | 28,000 | 5.04 | 141,120 |
| 2023-01-18 | Patel Sanjiv (President and CEO) | Sale | 28,000 | 20.87 | 584,360 |
| 2023-01-18 | Patel Sanjiv (President and CEO) | Option Ex | 28,000 | 5.04 | 141,120 |
| 2023-01-17 | Patel Sanjiv (President and CEO) | Sale | 28,000 | 20.23 | 566,440 |
| 2023-01-17 | Patel Sanjiv (President and CEO) | Option Ex | 28,000 | 5.04 | 141,120 |
| 2022-12-27 | Catinazzo Thomas (Chief Financial Officer) | Sale | 445 | 14.49 | 6,448 |
| 2022-12-27 | Bergstrom Donald A (President, R&D) | Sale | 980 | 14.49 | 14,200 |
Insider trading activities including stock purchases, stock sales, and option exercises of RLAY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Relay Therapeutics, Inc. (symbol RLAY, CIK number 1812364) see the Securities and Exchange Commission (SEC) website.